Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Juergens, S. M.
Right arrow Articles by Mulder, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Juergens, S. M.
Right arrow Articles by Mulder, D. W.
NEUROLOGY 1980;30:463
© 1980 American Academy of Neurology

ALS in Rochester, Minnesota, 1925–1977

Steven M. Juergens, M.D, Leonard T. Kurland, M.D., Dr. P.H, Haruo Okazaki, M.D and Donald W. Mulder, M.D.

Mayo Clinic and Mayo Foundation, Rochester, MN.

The incidence, trend, and survivorship of ALS in the population of Rochester, Minnesota, was determined for the years 1925 through 1977. The average annual incidence was 1.76 per 100,000 population. There was a small but nonsignificant increase in the rate during the 53-year period. The male:female ratio was 1.1, and the male:female ratio of incidence rates was 1.6. The median age at onset was 66 years; the incidence rates increased with increasing age. Median survivorship was 22.5 months, and was longer for younger patients than for patients with an advanced age at onset. The demographic characteristics in this total community experience are believed to reflect the pattern of ALS more accurately than previously reported clinical series.

Address correspondence and reprint requests to Dr. Kurland, Mayo Clinic, 200 First Street SW, Rochester, MN 55901

This investigation was supported in part by Research Grant No. GM-14231 from the National Institutes of Health, Public Health Service, and from the St. Gerard Foundation.

Accepted for publication September 4, 1979.




This article has been cited by other articles:


Home page
J. Neurol. Neurosurg. PsychiatryHome page
G Logroscino, B J Traynor, O Hardiman, A Chio', P Couratier, J D Mitchell, R J Swingler, E Beghi, and for EURALS
Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues
J. Neurol. Neurosurg. Psychiatry, January 1, 2008; 79(1): 6 - 11.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
Z. Simmons, S. H. Felgoise, B. A. Bremer, S. M. Walsh, D. J. Hufford, M. B. Bromberg, W. David, D. A. Forshew, T. D. Heiman-Patterson, E. C. Lai, et al.
The ALSSQOL: balancing physical and nonphysical factors in assessing quality of life in ALS.
Neurology, November 14, 2006; 67(9): 1659 - 1664.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
C. W. Noonan, M. C. White, D. Thurman, and L.-Y. Wong
Temporal and geographic variation in United States motor neuron disease mortality, 1969-1998
Neurology, April 12, 2005; 64(7): 1215 - 1221.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. Chio, R. Mutani, G. Mora, W.T. Longstreth Jr., and M.A. del Aguila
Prognosis in amyotrophic lateral sclerosis: A population-based study
Neurology, December 23, 2003; 61(12): 1826 - 1827.
[Full Text] [PDF]


Home page
NeurologyHome page
R. W. Haley
Excess incidence of ALS in young Gulf War veterans
Neurology, September 23, 2003; 61(6): 750 - 756.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M.A. del Aguila, W.T. Longstreth Jr, V. McGuire, T.D. Koepsell, and G. van Belle
Prognosis in amyotrophic lateral sclerosis: A population-based study
Neurology, March 11, 2003; 60(5): 813 - 819.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. Mandrioli, P. Faglioni, E. Merelli, and P. Sola
The epidemiology of ALS in Modena, Italy
Neurology, February 25, 2003; 60(4): 683 - 689.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
E. J. Sorenson, A. P. Stalker, L. T. Kurland, and A. J. Windebank
Amyotrophic lateral sclerosis in Olmsted County, Minnesota, 1925 to 1998
Neurology, July 23, 2002; 59(2): 280 - 282.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
C. S. Payne and A. D. Roses
The Molecular Genetic Revolution: Its Impact on Clinical Neurology
Arch Neurol, December 1, 1988; 45(12): 1366 - 1376.
[Abstract] [PDF]


Home page
Arch NeurolHome page
H. Mitsumoto, M. R. Hanson, and D. A. Chad
Amyotrophic Lateral Sclerosis: Recent Advances in Pathogenesis and Therapeutic Trials
Arch Neurol, February 1, 1988; 45(2): 189 - 202.
[Abstract] [PDF]


Home page
Arch NeurolHome page
J. E. Riggs
Trauma and Amyotrophic Lateral Sclerosis
Arch Neurol, March 1, 1985; 42(3): 205 - 205.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1980 by AAN Enterprises, Inc.